Patent Assignment
Reel/Frame 013852/0773
Collateral Assignment
Recorded: 2002-11-04
Pages: 12
Assignor
GENETIX PHARMACEUTICALS, INC.
Executed: 2002-09-19
Assignee
JOHNSON & JOHNSON DEVELOPMENT CORPORATION
ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NEW JERSEY, 08933
Covered Properties
(19)
Human Erythroid-Specific Transcriptional Enhancer
Patent:
5,126,260 →
Application:
07/622,356 →
Retroviral Vectors for Transducing Beta-Globin Gene and Beta-Locus Control Region Derivatives
Patent:
5,631,162 →
Application:
08/076,090 →
Vectors Containing Hiv Packaging Sequences, Packaging Defective Hiv Vectors, and Uses Thereof
Patent:
5,665,577 →
Application:
08/152,902 →
Chimeric Proteins Comprising a Vpr/Vpx Virion Incorporation Domain for Targeting into Hiv-1 or Hiv-2 Virions
Patent:
5,861,161 →
Application:
08/301,915 →
Isolated Dna Molecules for Intergration Site Independent Gene Expression in Mammalian Host Cells
Patent:
5,532,143 →
Application:
08/312,498 →
Retroviral Packaging Cell Lines and Processes of Using Same
Patent:
6,372,502 →
Application:
08/341,269 →
Methods and Compositions for Transforming Cells
Patent:
5,928,914 →
Application:
08/743,796 →
Compositions and Methods for Treating Sickle Cell Disease
Patent:
5,861,488 →
Application:
08/935,648 →
Magnetic Field Based Power Transmission Line Communication Method and System
Patent:
5,982,276 →
Application:
09/074,107 →
Compositions and Methods for Treating Sickle Cell Disease
Patent:
6,051,402 →
Application:
09/234,009 →
Methods and Compositions for Transforming Cells
Patent:
6,534,314 →
Application:
09/293,303 →
Novel Lentiviral Packaging Cells
Patent:
6,365,150 →
Application:
09/311,684 →
Methods and compositions for promoting angiogenesis using monocytes
Application:
09/860,657 →
Publication:
US 2002/0034501
Methods and compositions for promoting angiogenesis using polyethylene glycol (PEG) polymers
Application:
09/860,831 →
Publication:
US 2002/0013261
Novel self-inactivating (SIN) lentiviral vectors
Application:
10/137,788 →
Publication:
US 2003/0039636
Novel Lentiviral Packaging Cells
Application:
60/085,283 →
Methods and compositions for promoting angiogenesis
Application:
60/264,457 →
Method of treating arthritis using lentiviral vectors in gene therapy
Application:
60/284,736 →
Method for inhibiting angiogenesis
Application:
60/350,005 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 12, 1993
From: LEBOULCH, PHILIPPE; LONDON, IRVING M.; TUAN, DOROTHY
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 006910/0602 →
Assignment of Assignor's Interest
Jan 6, 1995
From: COHEN, ERIC A.; BERGERON, COMINIQUE; CHECROUNE, FLORENT; YAO, XIAO-JIAN
To: UNIVERSITE DE MONTREAL
Reel/Frame 007273/0724 →
Corrective Assignment to Correct the Spelling of the First Name of the Second Inventor.
Mar 11, 1996
From: COHEN, ERIC A.; BERGERON, DOMINIQUE; CHECROUNE, FLORENT; YAO, XIAO-JIAN
To: UNIVERSITE DE MONTREAL
Reel/Frame 007839/0314 →
Assignment of Assignor's Interest
Apr 20, 1998
From: LEBOULCH, PHILIPPE; WESTERMAN, KAREN; TAKEKOSHI, KEN JULIAN
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 009130/0476 →
Assignment of Assignor's Interest
Apr 20, 1998
From: BOUHASSIRA, ERIC
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIERSITY, A DIVISION OF YESHIVA UNIVERSITY
Reel/Frame 009130/0654 →
Assignment of Assignor's Interest
Jul 13, 1998
From: STEWART, WILLIAM L.
To: MEDIA FUSION CORP.
Reel/Frame 009329/0789 →
Assignment of Assignor's Interest
Sep 22, 1999
From: BOUHASSIRA, ERIC
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, A DIVISION OF YESHIVA UNIVERSITY
Reel/Frame 010253/0098 →
Assignment of Assignor's Interest
Sep 22, 1999
From: LEBOULCH, PHILIPPE
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 010278/0434 →
Assignment of Assignor's Interest
Sep 24, 1999
From: LEBOULCH, PHILIPPE; WESTERMAN, KAREN
To: GENETIX PHARMACEUTICALS, INC.
Reel/Frame 010254/0921 →
Merger
Sep 15, 2000
From: MEDIA FUSION, CORP.
To: MEDIS FUSION, LLC
Reel/Frame 011103/0182 →
Assignment of Assignor's Interest
Oct 16, 2000
From: MEDIA FUSION, LLC
To: MEDIA FUSION HOLDINGS, INC.
Reel/Frame 011177/0571 →
Assignment of Assignor's Interest
Oct 25, 2000
From: MEDIA FUSION, LLC
To: MEDIA FUSION HOLDINGS, INC.
Reel/Frame 011058/0075 →
Assignment of Assignor's Interest
Oct 25, 2000
From: MEDIA FUSION CORP.
To: MEDIA FUSION, LLC
Reel/Frame 011052/0344 →
Assignment of Assignor's Interest
Oct 25, 2000
From: MEDIA FUSION HOLDINGS, INC.
To: MEDIA FUSION, INC.
Reel/Frame 011052/0335 →
Corrective Assignment to Correct the Receiving Party Previously Recorded at Reel 011103 Frame 0182.
Jan 22, 2001
From: MEDIA FUSION CORP.
To: MEDIA FUSION, LLC
Reel/Frame 011497/0129 →
Security Agreement
Jul 19, 2001
From: MEDIA FUSION, INC. F/K/A MFH ACQUISITION CORP.
To: DETORE, ROBERT R.; KINKEAD, MICHAEL
Reel/Frame 012002/0085 →
Notice of Default and Intent to Foreclose
Aug 27, 2001
From: MEDIA FUSION, INC. F/K/A MFH ACQUISTION CORP.
To: ROBERT R. DETORE; MICHAEL KINKEAD
Reel/Frame 012110/0101 →
Assignment of Assignor's Interest
Sep 20, 2001
From: PAWLIUK, ROBERT; LEBOULCH, PHILIPPE
To: GENETIX PHARMACEUTICALS, INC.
Reel/Frame 012186/0175 →
Assignment of Assignor's Interest
Sep 27, 2001
From: PAWLIUK, ROBERT; LEBOULCH, PHILIPPE
To: GENETIX PHARMACEUTICALS, INC.
Reel/Frame 012198/0059 →
Order Granting Stewart's Motion for Summary Judgement Against Media Fusion, Inc.
Feb 1, 2002
From: MEDIA FUSION, INC.
To: STEWART, WILLIAM L.
Reel/Frame 012569/0065 →
Security Agreement
Apr 1, 2002
From: DETORE, ROBERT R.; KINKEAD, MICHAEL
To: POWERMEDIA & COMMUNICATIONS, INC.
Reel/Frame 012735/0799 →
Media Fusion, Inc. Consent to Foreclosure by Powermedia & Communications, Inc.
Apr 1, 2002
From: MEDIA FUSION, INC.
To: POWERMEDIA & COMMUNICATIONS, INC.
Reel/Frame 012745/0004 →
Assignment of Assignor's Interest
Aug 15, 2002
From: LEBOULCH, PHILIPPE; WESTERMAN, KAREN
To: GENETIX PHARMACEUTICALS, INC.
Reel/Frame 013214/0414 →
Security Release Letter
May 20, 2004
From: JOHNSON & JOHNSON DEVELOPMENT CORPORATION
To: GENETIX PHARMACEUTICALS INC.
Reel/Frame 015348/0735 →
Assent Agreement
Apr 4, 2005
From: COBRA THERAPEUTICS LIMITED
To: M.L. LABORATORIES PLC
Reel/Frame 015991/0712 →